Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement
May 01, 2017 11:30 am UTC| Business
COPENHAGEN, Denmark, May 01, 2017 -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”) today provided an update on the Company’s strategic focus and related initiatives to reduce operating and...
May 01, 2017 11:30 am UTC| Business
SOUTH SAN FRANCISCO, Calif., May 01, 2017 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that results from the dose escalation phase of COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility...
Intra-Cellular Therapies Provides Corporate Update On Schizophrenia Program
May 01, 2017 11:30 am UTC| Business
NEW YORK, May 01, 2017 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today provided a corporate...
KemPharm, Inc. to Report First Quarter 2017 Results
May 01, 2017 11:30 am UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled forMay 10, 2017, 4:30 p.m. ET CORALVILLE, Iowa, May 01, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical...
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2017 Financial Results
May 01, 2017 11:30 am UTC| Business
RADNOR, Pa., May 01, 2017 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric...
Flexion Therapeutics to Present at the Deutsche Bank 42nd Annual Health Care Conference
May 01, 2017 11:30 am UTC| Business
BURLINGTON, Mass., May 01, 2017 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President, Commercial, will...
Macatawa Bank Corporation Declares Quarterly Dividend
May 01, 2017 11:30 am UTC| Business
HOLLAND, Mich., May 01, 2017 -- Macatawa Bank Corporation (Nasdaq:MCBC) (the "Company" or "Macatawa") today announced that its Board of Directors has declared a quarterly cash dividend of $0.04 per share on its common...